Open AccessThe significance of serum leptin level in patients with early stage nonsmall cell lung cancer
Author(s) -
Fatih Karataş,
Bülent Yalçın,
Süleyman Şahin,
Hakan Akbulut,
Güngör Utkan,
Ahmet Demirkazık,
Fikri İçlı
Publication year - 2017
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.196859
Subject(s) - medicine , adenocarcinoma , lung cancer , stage (stratigraphy) , oncology , cachexia , gastroenterology , biomarker , carcinoma , cancer , leptin , obesity , biology , paleontology , biochemistry
The serum leptin level (SLL) has been shown to increase in patients with nonsmall cell lung cancer (NSCLC). However, available data regarding the relation between SLL and tumor subtypes, survival, cachexia, and tumor respectability in NSCLC are still under debate. The aim of this study is to evaluate SLL in NSCLC patients with and without cachexia.